174 related articles for article (PubMed ID: 10361962)
1. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
Krüger MB; Dahl AA
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
[TBL] [Abstract][Full Text] [Related]
2. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
Tiller JW; Bouwer C; Behnke K
Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Tiller JW; Bouwer C; Behnke K
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
[TBL] [Abstract][Full Text] [Related]
4. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
Larsen JK; Holm P; Mikkelsen PL
Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
Lecrubier Y; Pedarriosse AM; Payan C; Schmid-Burgk W; Stabl M
Acta Psychiatr Scand; 1995 Oct; 92(4):260-5. PubMed ID: 8848950
[TBL] [Abstract][Full Text] [Related]
7. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
[TBL] [Abstract][Full Text] [Related]
9. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
11. Medication treatments for panic disorder and social phobia.
Stein MB
Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
[TBL] [Abstract][Full Text] [Related]
12. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Bakker A; Dunbar G; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Funke HJ; Moritz E; Hellstern K; Malanowski H
Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
19. Combined SSRI-moclobemide treatment of psychiatric illness.
Joffe RT; Bakish D
J Clin Psychiatry; 1994 Jan; 55(1):24-5. PubMed ID: 8294388
[TBL] [Abstract][Full Text] [Related]
20. Reversible monoamine-A inhibitors in panic disorder.
Bakish D
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():432A-433A. PubMed ID: 1498904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
